IBDEI1CQ ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,21844,1,4,0)
 ;;=4^J45.20
 ;;^UTILITY(U,$J,358.3,21844,2)
 ;;=^5008242
 ;;^UTILITY(U,$J,358.3,21845,0)
 ;;=J45.21^^70^931^18
 ;;^UTILITY(U,$J,358.3,21845,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21845,1,3,0)
 ;;=3^Mild Intermittent Asthma w/ Exacerbation
 ;;^UTILITY(U,$J,358.3,21845,1,4,0)
 ;;=4^J45.21
 ;;^UTILITY(U,$J,358.3,21845,2)
 ;;=^5008243
 ;;^UTILITY(U,$J,358.3,21846,0)
 ;;=J45.31^^70^931^21
 ;;^UTILITY(U,$J,358.3,21846,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21846,1,3,0)
 ;;=3^Mild Persistent Asthma w/ Exacerbation
 ;;^UTILITY(U,$J,358.3,21846,1,4,0)
 ;;=4^J45.31
 ;;^UTILITY(U,$J,358.3,21846,2)
 ;;=^5008246
 ;;^UTILITY(U,$J,358.3,21847,0)
 ;;=J45.32^^70^931^22
 ;;^UTILITY(U,$J,358.3,21847,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21847,1,3,0)
 ;;=3^Mild Persistent Asthma w/ Status Asthmaticus
 ;;^UTILITY(U,$J,358.3,21847,1,4,0)
 ;;=4^J45.32
 ;;^UTILITY(U,$J,358.3,21847,2)
 ;;=^5008247
 ;;^UTILITY(U,$J,358.3,21848,0)
 ;;=J45.30^^70^931^23
 ;;^UTILITY(U,$J,358.3,21848,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21848,1,3,0)
 ;;=3^Mild Persistent Asthma,Uncomplicated
 ;;^UTILITY(U,$J,358.3,21848,1,4,0)
 ;;=4^J45.30
 ;;^UTILITY(U,$J,358.3,21848,2)
 ;;=^5008245
 ;;^UTILITY(U,$J,358.3,21849,0)
 ;;=J45.41^^70^931^24
 ;;^UTILITY(U,$J,358.3,21849,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21849,1,3,0)
 ;;=3^Moderate Persistent Asthma w/ Exacerbation
 ;;^UTILITY(U,$J,358.3,21849,1,4,0)
 ;;=4^J45.41
 ;;^UTILITY(U,$J,358.3,21849,2)
 ;;=^5008249
 ;;^UTILITY(U,$J,358.3,21850,0)
 ;;=J45.42^^70^931^25
 ;;^UTILITY(U,$J,358.3,21850,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21850,1,3,0)
 ;;=3^Moderate Persistent Asthma w/ Status Asthmaticus
 ;;^UTILITY(U,$J,358.3,21850,1,4,0)
 ;;=4^J45.42
 ;;^UTILITY(U,$J,358.3,21850,2)
 ;;=^5008250
 ;;^UTILITY(U,$J,358.3,21851,0)
 ;;=J45.40^^70^931^26
 ;;^UTILITY(U,$J,358.3,21851,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21851,1,3,0)
 ;;=3^Moderate Persistent Asthma,Uncomplicated
 ;;^UTILITY(U,$J,358.3,21851,1,4,0)
 ;;=4^J45.40
 ;;^UTILITY(U,$J,358.3,21851,2)
 ;;=^5008248
 ;;^UTILITY(U,$J,358.3,21852,0)
 ;;=J41.1^^70^931^27
 ;;^UTILITY(U,$J,358.3,21852,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21852,1,3,0)
 ;;=3^Mucopurulent Chr Bronchitis
 ;;^UTILITY(U,$J,358.3,21852,1,4,0)
 ;;=4^J41.1
 ;;^UTILITY(U,$J,358.3,21852,2)
 ;;=^269949
 ;;^UTILITY(U,$J,358.3,21853,0)
 ;;=J45.998^^70^931^2
 ;;^UTILITY(U,$J,358.3,21853,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21853,1,3,0)
 ;;=3^Asthma NEC
 ;;^UTILITY(U,$J,358.3,21853,1,4,0)
 ;;=4^J45.998
 ;;^UTILITY(U,$J,358.3,21853,2)
 ;;=^5008257
 ;;^UTILITY(U,$J,358.3,21854,0)
 ;;=J43.8^^70^931^15
 ;;^UTILITY(U,$J,358.3,21854,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21854,1,3,0)
 ;;=3^Emphysema NEC
 ;;^UTILITY(U,$J,358.3,21854,1,4,0)
 ;;=4^J43.8
 ;;^UTILITY(U,$J,358.3,21854,2)
 ;;=^87569
 ;;^UTILITY(U,$J,358.3,21855,0)
 ;;=J43.1^^70^931^28
 ;;^UTILITY(U,$J,358.3,21855,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21855,1,3,0)
 ;;=3^Panlobular Emphysema
 ;;^UTILITY(U,$J,358.3,21855,1,4,0)
 ;;=4^J43.1
 ;;^UTILITY(U,$J,358.3,21855,2)
 ;;=^5008236
 ;;^UTILITY(U,$J,358.3,21856,0)
 ;;=J45.51^^70^931^29
 ;;^UTILITY(U,$J,358.3,21856,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21856,1,3,0)
 ;;=3^Severe Persistent Asthma w/ Exacerbation
 ;;^UTILITY(U,$J,358.3,21856,1,4,0)
 ;;=4^J45.51
 ;;^UTILITY(U,$J,358.3,21856,2)
 ;;=^5008252
